Clinical Trials
16 trialsNCT06280781 2026-03-30
IP9-ATLAS
Imperial College London
Phase NA Recruiting
NCT06238661 2026-03-05
ProScreenMRI
Fondazione del Piemonte per l'Oncologia
Phase NA Enrolling by invitation
NCT04685928 2025-05-06
SMART
Chinese University of Hong Kong
Phase NA Completed
NCT02163317 2024-05-10
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT06185478 2023-12-29
Prostate Diffusion Imaging With Distortion Correction
Norfolk and Norwich University Hospitals NHS Foundation Trust
Phase NA Suspended
NCT03987568 2022-12-21
Characterize Tumor Hypoxia by Magnetic Resonance Imaging
Wake Forest University Health Sciences
Phase NA Withdrawn
NCT05603351 2022-11-02
ProstaPilot
Masaryk Memorial Cancer Institute
Phase NA Unknown
NCT02681614 2022-06-30
Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning
Case Comprehensive Cancer Center
Phase NA Completed
NCT03238170 2022-03-18
FIMRA-P
Guy's and St Thomas' NHS Foundation Trust
Phase NA Unknown
NCT04803188 2021-03-17
ProSa-I
University of Roma La Sapienza
Phase NA Unknown
NCT02488096 2020-01-21
Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided Biopsy
Saskatchewan Health Authority - Regina Area
Phase NA Completed
NCT02470910 2019-12-11
Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning
Dana-Farber Cancer Institute
Phase NA Completed
NCT02786459 2019-06-03
ProxiScan
University Health Network, Toronto
Phase NA Completed
NCT00851682 2018-10-31
Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma
Washington University School of Medicine
Phase NA Terminated
NCT01357512 2017-12-02
Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer
University of Oulu
Phase NA Completed
NCT02516995 2016-02-10
FIBROP
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Completed